PPARA and diabetic retinopathy: ,402 Fenofibrate, a PPARα agonist commonly used to lower triglyceride, was shown to slow the progression of diabetic retinopathy in the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study.403